SCHEMBL23192514

SCHEMBL23192514

O=C1NN=C(c2ccccc2)/C1=C\Nc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.57
LMNA P02545 4/20 0.57
KDR P35968 2/20 0.49
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
GSK3B P49841 1/20 0.35
SMN1; SMN2 Q16637 5/20 0.35
GAA P10253 4/20 0.35
NAMPT P43490 1/20 0.35
MAP1LC3B Q9GZQ8 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
S1PR4 O95977 1/20 0.34
PKM P14618 1/20 0.34
S1PR1 P21453 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 3/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17481601 1.00 ALDH1A1 (0.57) ALDH1A1LMNAKDRHSP90AA1HSP90AB1
SCHEMBL17481602 0.90 ALDH1A1 (0.55) ALDH1A1LMNAKDRSMN1; SMN2GAA
SCHEMBL17481600 0.87 ALDH1A1 (0.51) ALDH1A1LMNAKDRGSK3BSMN1; SMN2
SCHEMBL4865457 0.81 ALDH1A1 (0.42) ALDH1A1LMNAKDRSMN1; SMN2GAA
SCHEMBL4865450 0.81 ALDH1A1 (0.42) ALDH1A1LMNAKDRSMN1; SMN2GAA
SCHEMBL29203721 0.76 LMNA (0.62) ALDH1A1LMNAKDRSMN1; SMN2GAA
SCHEMBL11689513 0.73 KMT2A (0.59) ALDH1A1LMNAGAAMEN1KMT2A
SCHEMBL10036006 0.73 KMT2A (0.59) ALDH1A1LMNAGAAMEN1KMT2A
SCHEMBL11689520 0.73 KMT2A (0.59) ALDH1A1LMNAGAAMEN1KMT2A
SCHEMBL6736006 0.70 ALDH1A1 (0.54) ALDH1A1LMNAKDRSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3799871-A2 PYRAZOL-3-ONES THAT ACTIVATE PRO-APOTOTIC BAX Dana Farber Cancer Institute, Inc. (US) 2021-04-07 EP disclosed